Record ID | ia:antimicrobialage0000unse_t6w2 |
Source | Internet Archive |
Download MARC XML | https://archive.org/download/antimicrobialage0000unse_t6w2/antimicrobialage0000unse_t6w2_marc.xml |
Download MARC binary | https://www.archive.org/download/antimicrobialage0000unse_t6w2/antimicrobialage0000unse_t6w2_meta.mrc |
LEADER: 07870cam 2200997Ia 4500
001 ocn647876336
003 OCoLC
005 20200521011334.0
008 050708s2005 dcua ob 001 0 eng d
006 m o d
007 cr cn|||||||||
010 $z 2005019538
040 $aE7B$beng$epn$cE7B$dOCLCQ$dUIU$dOCLCF$dDKDLA$dOCLCO$dOCLCQ$dCUS$dOCLCQ$dTETON$dWUOHS$dEBLCP$dMERUC$dYDXCP$dIDEBK$dOCLCQ$dAZK$dCOCUF$dZ5A$dMOR$dOCLCO$dPIFAG$dZCU$dOCLCQ$dN$T$dOCLCQ$dIGB$dOCLCO$dAGLDB$dOCLCO$dOCLCA$dU3W$dOCLCA$dGRG$dOCLCO$dD6H$dOCLCO$dCN8ML$dSTF$dOCLCO$dVNS$dWRM$dOCLCQ$dVTS$dICG$dVT2$dAU@$dOCLCO$dOCLCQ$dWYU$dOCLCA$dS9I$dOCLCO$dDKC$dOCLCQ$dM8D$dOCLCO$dUX1$dOCLCQ$dOCLCA$dOCLCQ$dOCLCA$dUKCRE
066 $c(S
019 $a276170078$a536370622$a609854739$a764532018$a872026030$a961507091$a962584840$a988473714$a991914334$a1037912651$a1038593365$a1055362656$a1058037491$a1062875357$a1081212601$a1153533754
020 $a9781555815929$q(electronic bk.)
020 $a1555815928$q(electronic bk.)
020 $z1555812376
020 $z9781555812379
035 $a(OCoLC)647876336$z(OCoLC)276170078$z(OCoLC)536370622$z(OCoLC)609854739$z(OCoLC)764532018$z(OCoLC)872026030$z(OCoLC)961507091$z(OCoLC)962584840$z(OCoLC)988473714$z(OCoLC)991914334$z(OCoLC)1037912651$z(OCoLC)1038593365$z(OCoLC)1055362656$z(OCoLC)1058037491$z(OCoLC)1062875357$z(OCoLC)1081212601$z(OCoLC)1153533754
037 $atds266$bTeton Data Systems$nhttp://www.statref.com
041 1 $aeng$hfre
050 4 $aRM267$b.A54313 2005eb
060 4 $a2005 O-288
060 4 $aQV 350$bA6306 2005a
072 7 $aMED$x071000$2bisacsh
082 04 $a615/.329$222
130 0 $aAntibiotiques, agents antibactériens et antifongiques.$lEnglish.
245 10 $aAntimicrobial agents :$bantibacterials and antifungals /$cedited by André Bryskier.
260 $aWashington, D.C. :$bASM Press,$c©2005.
300 $a1 online resource (xxx, 1426 pages) :$billustrations
336 $atext$btxt$2rdacontent
337 $acomputer$bc$2rdamedia
338 $aonline resource$bcr$2rdacarrier
347 $adata file$2rda
504 $aIncludes bibliographical references and index.
588 0 $aPrint version record.
520 8 $aAnnotation Antimicrobial Agents: Antibacterials and Antifungals is a significant revision of an original French reference published by Ellipses in 1999. Offers hundreds of antibiotics and antimicrobial compounds: in development, experimental, and in use. Provides a thorough update of the original French edition published in 1999, plus critical new material. Presents comprehensive coverage of chemistry and synthesis, classification, structure-activity relationships, mechanisms of action and resistance, breakpoints, in vitro/in vivo activities, epidemiology, pharmacokinetics, metabolism, and adverse eventsFeatures over 1,200 illustrations, over 1,500 tables, and more than 3,000 references. Presents new, extensive chapters covering helicobacter pylori and methicillin-resistant Staphylococcus aureus (MSRA).
505 0 $aContents; Foreword; Foreword to the First Edition, Revised; Foreword to the First Edition; Preface; Contributors; 1 Historical Review of Antibacterial Chemotherapy; 2 Antibiotics and Antibacterial Agents: Classifications and Structure-Activity Relationship; 3 Epidemiology of Resistance to Antibacterial Agents; 4 Development of an Antibiotic: Microbiology; 5 Penicillins; 6 Cephems for Parenteral Use; 7 Oral Cephalosporins; 8 Carbapenems; 9 Penems; 10 Monocyclic ß-Lactams; 11 ß-Lactam Prodrugs; 12 Peptidoglycan Synthesis Inhibitors; 13 ß-Lactamase Inhibitors.
505 8 $a14 ß-Lactamase Inhibitors under Research15?-Lactams and Derivatives; 16 Aminocyclitol Aminoglycosides; 17 Spectinomycin; 18 Macrolides; 19 Ketolides; 20 Streptogramins; 21 Lincosamines; 22 Oxazolidinones; 23 Fusidic Acid; 24 Tetracyclines; 25 Tetracyclines under Investigation; 26 Fluoroquinolones; 27 DNA Gyrase Inhibitors Other Than Fluoroquinolones; 28 Codrugs; 29 Coumarin Antibiotics: Novobiocin, Coumermycin, and Clorobiocin; 30 Peptide.
546 $aTranslated from 1st French rev. ed. of: Antibiotiques, agents antibactériens et antifongiques. 1999.
650 0 $aAntibiotics.
650 6 $aAntibiotiques.
650 6 $aAntibactériens.
650 6 $aAntifongiques.
650 7 $aMEDICAL$xPharmacology.$2bisacsh
650 7 $aAntibiotics.$2fast$0(OCoLC)fst00810420
650 17 $aAntimicrobiële middelen.$2gtt
650 7 $aAntibióticos.$2larpcal
650 7 $aAntimicóticos.$2larpcal
650 4 $aAnti-Bacterial agents$xPharmacology.
650 4 $aAntibiotics.
650 4 $aAntifungal agents$xPharmacology.
650 12 $aAnti-Bacterial Agents$xpharmacology.
650 22 $aAntifungal Agents$xpharmacology.
655 4 $aElectronic books.
700 1 $aBryskier, André,$eeditor.
776 08 $iPrint version:$tAntimicrobial agents.$dWashington, D.C. : ASM Press, ©2005$z1555812376$w(DLC) 2005019538$w(OCoLC)60856143
856 40 $3ASM$uhttp://www.asmscience.org/content/book/10.1128/9781555815929
856 40 $3ProQuest Ebook Central$uhttps://public.ebookcentral.proquest.com/choice/publicfullrecord.aspx?p=480216
856 40 $3ebrary$uhttp://site.ebrary.com/id/10365032
856 40 $3EBSCOhost$uhttps://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=1084282
856 40 $3MyiLibrary$uhttp://www.myilibrary.com?id=301819
856 40 $3STAT!Ref$uhttp://online.statref.com/document.aspx?FxId=266&DocID=1&grpalias=
856 40 $3STAT!Ref$uhttp://online.statref.com/document.aspx?FxId=266&grpalias=
856 40 $uhttp://portal.igpublish.com/iglibrary/search/ASMB0000038.html
856 41 $3MyiLibrary, Table of contents$uhttp://www.myilibrary.com?id=301819&ref=toc
856 41 $3Table of contents$uhttp://catdir.loc.gov/catdir/toc/ecip0515/2005019538.html
856 40 $uhttp://VH7QX3XE2P.search.serialssolutions.com/?V=1.0&L=VH7QX3XE2P&S=JCs&C=TC0000078965&T=marc&tab=BOOKS
856 40 $uhttp://ebookcentral.proquest.com/lib/ucreative-ebooks/detail.action?docID=480216$zConnect to Ebook.
880 0 $6505-00/(S$aContents; Foreword; Foreword to the First Edition, Revised; Foreword to the First Edition; Preface; Contributors; 1 Historical Review of Antibacterial Chemotherapy; 2 Antibiotics and Antibacterial Agents: Classifications and Structure-Activity Relationship; 3 Epidemiology of Resistance to Antibacterial Agents; 4 Development of an Antibiotic: Microbiology; 5 Penicillins; 6 Cephems for Parenteral Use; 7 Oral Cephalosporins; 8 Carbapenems; 9 Penems; 10 Monocyclic β-Lactams; 11 β-Lactam Prodrugs; 12 Peptidoglycan Synthesis Inhibitors; 13 β-Lactamase Inhibitors.
880 8 $6505-00/(S$a14 β-Lactamase Inhibitors under Research15 γ-Lactams and Derivatives; 16 Aminocyclitol Aminoglycosides; 17 Spectinomycin; 18 Macrolides; 19 Ketolides; 20 Streptogramins; 21 Lincosamines; 22 Oxazolidinones; 23 Fusidic Acid; 24 Tetracyclines; 25 Tetracyclines under Investigation; 26 Fluoroquinolones; 27 DNA Gyrase Inhibitors Other Than Fluoroquinolones; 28 Codrugs; 29 Coumarin Antibiotics: Novobiocin, Coumermycin, and Clorobiocin; 30 Peptide Antibiotics; 31 Glycopeptides and Lipoglycopeptides; 32 Ansamycins; 33 Phenicols; 34 5-Nitroimidazoles.
938 $aProQuest Ebook Central$bEBLB$nEBL480216
938 $aebrary$bEBRY$nebr10365032
938 $aEBSCOhost$bEBSC$n1084282
938 $aProQuest MyiLibrary Digital eBook Collection$bIDEB$n301819
938 $aTeton Data Systems$bSTAT$ntds266
938 $aYBP Library Services$bYANK$n3163359
029 1 $aAU@$b000045983999
029 1 $aAU@$b000053268353
029 1 $aDEBBG$bBV044141725
029 1 $aGBVCP$b785194436
029 1 $aNZ1$b13845017
029 1 $aNZ1$b13863187
994 $aZ0$bP4A
948 $hHELD BY P4A - 1056 OTHER HOLDINGS